- Investing Ideas
- /
- Danish Healthy potentially undervalued
Danish Healthy potentially undervalued
Results
8
Companies which are potentially undervalued and in an acceptable financial position.
8 companies
Demant
Market Cap: DKK 45.6b
Operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally.
DEMANT
DKK 214.00
7D
0.6%
1Y
-18.3%
H. Lundbeck
Market Cap: DKK 41.1b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 43.00
7D
0.2%
1Y
3.3%
Genmab
Market Cap: DKK 130.8b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 2,123.00
7D
5.9%
1Y
43.0%
Jyske Bank
Market Cap: DKK 50.8b
Provides financial solutions in Denmark and Germany.
JYSK
DKK 865.50
7D
2.7%
1Y
73.6%
Novo Nordisk
Market Cap: DKK 1.5t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 331.55
7D
9.0%
1Y
-46.7%
ISS
Market Cap: DKK 35.0b
Operates as workplace experience and facility management company in the United Kingdom, Ireland, the United States, Canada, Switzerland, Germany, Australia, New Zealand, Türkiye, Spain, Denmark, and internationally.
ISS
DKK 215.00
7D
1.5%
1Y
65.8%
TORM
Market Cap: DKK 12.6b
A shipping company, owns and operates a fleet of product tankers in the United Kingdom.
TRMD A
DKK 124.15
7D
-1.1%
1Y
-7.5%
FLSmidth
Market Cap: DKK 24.0b
Provides flowsheet technology and service solutions for the mining and cement industries in Denmark, the United States of America, Canada, Chile, Brazil, Peru, Australia, North and South America, Europe, the Middle East, Africa, and Asia.
FLS
DKK 438.60
7D
-0.5%
1Y
23.3%